Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma
Samuels, Brian L., Chawla, Sant P., Somaiah, Neeta, Staddon, Arthur P., Skubitz, Keith M., Milhem, Mohammed M., Kaiser, Pamela E., Portnoy, David C., Priebat, Dennis A., Walker, Mark S., Stepanski, EdLanguage:
english
Journal:
Cancer
DOI:
10.1002/cncr.30926
Date:
August, 2017
File:
PDF, 296 KB
english, 2017